Skip to content

Opening book details…

About this Medicine article

Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al by Bredemeier, Markus (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Bredemeier, Markus (author)
Publisher
Wiley
Published
2021
Field
Medicine (Health Sciences)

More by Bredemeier, Markus (author)

Browse all works by Bredemeier, Markus (author)